Akebia Therapeutics Inc (NASDAQ:AKBA)

0.30
Delayed Data
As of 3:21pm ET
 0.00 / 0.00%
Today’s Change
0.24
Today|||52-Week Range
2.93
-86.73%
Year-to-Date
No recent news for Akebia Therapeutics Inc.

Today’s Trading

Previous close0.30
Today’s open0.31
Day’s range0.29 - 0.31
Volume202,029
Average volume (3 months)2,016,176
Market cap$53.2M
Data as of 3:21pm ET, 12/08/2022

Growth & Valuation

Earnings growth (last year)+38.46%
Earnings growth (this year)+65.29%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)-27.68%
P/E ratioNM
Price/Sales1.76
Price/Book0.67

Competitors

 Today’s
change
Today’s
% change
ORTXOrchard Therapeutics...-0.00-1.13%
OCXOncoCyte Corp-0.05-10.16%
ABEOAbeona Therapeutics ...-0.06-1.85%
TXMDTherapeuticsMD Inc+1.54+34.53%
Data as of 3:16pm ET, 12/08/2022

Financials

Next reporting dateMarch 14, 2023
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$213.6M
Annual profit (last year)-$282.8M
Net profit margin-132.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts